Riad Mishlawi to become CEO of Hikma Pharma
New Delhi: Generic drugmaker Hikma Pharmaceuticals Plc said on Wednesday that Riad Mishlawi, president of the group’s injectables business, will become its chief executive officer, effective Sept. 1. The London-based company said once Mishlawi takes up the role, Said Darwazah will step down as acting CEO and return to his role as executive chairman. Mishlawi, […] More